A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
Loibl, S., Schneeweiss, A., Huober, J., Braun, M., Rey, J., Blohmer, J.-U., Furlanetto, J., Zahm, D.-M., Hanusch, C., Thomalla, J., Jackisch, C., Staib, P., Link, T., Rhiem, K., Solbach, C., Fasching, P.A., Nekljudova, V., Denkert, C., Untch, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Central venous access in oncology: ESMO Clinical Practice Guidelines
Sousa, B., Furlanetto, J., Hutka, M., Gouveia, P., Wuerstlein, R., Mariz, J.M., Pinto, D., Cardoso, F.
Published in Annals of oncology (01.09.2015)
Published in Annals of oncology (01.09.2015)
Get full text
Journal Article
Identifying N fertilizer management strategies to reduce ammonia volatilization: Towards a site-specific approach
Mencaroni, M., Dal Ferro, N., Furlanetto, J., Longo, M., Lazzaro, B., Sartori, L., Grant, B.B., Smith, W.N., Morari, F.
Published in Journal of environmental management (01.01.2021)
Published in Journal of environmental management (01.01.2021)
Get full text
Journal Article
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288]
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.07.2022)
Published in Annals of oncology (01.07.2022)
Get full text
Journal Article
Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast cancer: A phase II trial (AMICA) GBG 97
Decker, T., Denkert, C., Lübbe, K., Müller, V., Mundhenke, C., Furlanetto, J., Schmidt, M., Thill, M., Tierbach, V., Seither, F., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Reply to the letter to the editor ‘Insertion of central venous catheters (CVCs): any changes in the past ten years’ by Biffi et al
Pinto, D., Gouveia, P., Sousa, B., Hutka, M., Furlanetto, J., Mariz, J.M., Wuerstlein, R., Cardoso, F.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
Villegas, S. L., Darb-Esfahani, S., von Minckwitz, G., Huober, J., Weber, K., Marmé, F., Furlanetto, J., Schem, C., Pfitzner, B. M., Lederer, B., Engels, K., Kümmel, S., Müller, V., Mehta, K., Denkert, C., Loibl, S.
Published in Breast cancer research and treatment (01.02.2018)
Published in Breast cancer research and treatment (01.02.2018)
Get full text
Journal Article
Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC)
Untch, M., Jackisch, C., Schneeweiss, A., Schmatloch, S., Aktas, B., Denkert, C., Schem, C., Wiebringhaus, H., Kümmel, S., Rhiem, K., Warm, M., Fasching, P.A., Just, M., Hanusch, C., Hackmann, J., Blohmer, J.-U., Furlanetto, J., Nekljudova, V., von Minckwitz, G., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study
Pohl, E., Schneeweiss, A., Hauke, J., Moebus, V., Furlanetto, J., Denkert, C., Fasching, P.A., Hanusch, C., Tesch, H., Weber-Lassalle, N., Müller, V., Rhiem, K., Untch, M., Luebbe, K., Lederer, B., Jackisch, C., Nekljudova, V., Schmutzler, R.K., Hahnen, E., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)
Schmidt, M., Lübbe, K., Decker, T., Thill, M., Bauer, L., Müller, V., Link, T., Furlanetto, J., Reinisch, M., Mundhenke, C., Hoffmann, O., Zahn, M.-O., Müller, L., Denkert, C., van Mackelenbergh, M., Fasching, P.A., Burchardi, N., Nekljudova, V., Loibl, S.
Published in ESMO open (01.12.2022)
Published in ESMO open (01.12.2022)
Get full text
Journal Article
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
Marmé, F., Martin, M., Untch, M., Thode, C., Bonnefoi, H., Kim, S.-B., Bear, H., Mc Carthy, N., Gelmon, K., García-Sáenz, J.A., Kelly, C.M., Reimer, T., Valota, O., Toi, M., Rugo, H.S., Gnant, M., Makris, A., Bassy, M., Zhang, Z., Furlanetto, J., Nekljudova, V., Loibl, S.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study
Furlanetto, J., Eiermann, W., Marmé, F., Reimer, T., Reinisch, M., Schmatloch, S., Stickeler, E., Thomssen, C., Untch, M., Denkert, C., von Minckwitz, G., Lederer, B., Nekljudova, V., Weber, K., Loibl, S., Möbus, V.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article
Diagnostic assessment to estimate and minimize neutron dose rates received by occupationally exposed individuals at cyclotron facilities
Reina, L.C., Silva, A.X., Suita, J.C., Souza, M.I.S., Facure, A., Silva, J.C.P., Furlanetto, J.A.D., Rebello, W.
Published in Applied radiation and isotopes (01.03.2010)
Published in Applied radiation and isotopes (01.03.2010)
Get full text
Journal Article
Dispersal acts as both bane and balm for invaded zooplankton communities
Sinclair, James S., Furlanetto, Katrina J., Arnott, Shelley E.
Published in Journal of plankton research (01.03.2015)
Published in Journal of plankton research (01.03.2015)
Get full text
Journal Article
999MO HARE-40: A phase I/II trial of therapeutic HPV vaccine (BNT113) in patients with HPV16 driven carcinoma
Ottensmeier, C.H.H., King, E., Crabb, S., Karydis, I., Graham, D.M., Martin, K., Eberhart, I., Ewings, S., Lee, P., McCann, K., Chudley, L., Berry, L., Dias, J., Das, R., Furlanetto, J., Johnson, E., Setzer, J., Sahin, U., Türeci, Ö., Griffiths, G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
877P Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+ HNSCC
Saba, N.F., Klinghammer, K., Castelluci, E., Colevas, A.D., Rutkowski, T., Thurner, D., Müller-Richter, U., Maio, M., Grewal, J.S., Ottensmeier, C.H.H., Dias, J., Yang, H., Das, R., Furlanetto, J., Herzfeldt, A-K., Kühnle, M-C., Ulges, A., Alles, J., Türeci, Ö., Sahin, U.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article